Results 211 to 220 of about 128,389 (322)

Bcr/Abl associated leukemogenesis in bcr null mutant mice

open access: bronze, 1998
Jan Willem Voncken   +3 more
openalex   +1 more source

Co-Occurrence of Jak2-Positive Myelofibrosis and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. [PDF]

open access: yesMediterr J Hematol Infect Dis
Paciaroni K   +8 more
europepmc   +1 more source

Stem cells in chronic myeloid leukaemia [PDF]

open access: yes, 2007
Holyoake, T., Pellicano, F.
core   +1 more source

Unveiling the nephrotoxic profile of BCR-ABL tyrosine kinase inhibitors: A real-world experience in Africa. [PDF]

open access: yesEJHaem
Ayalew ZS   +8 more
europepmc   +1 more source

A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA

open access: yesOncogene, 2014
G. Guo   +13 more
semanticscholar   +1 more source

Specific human cellular immunity to bcr-abl oncogene-derived peptides

open access: bronze, 1996
Monica Bocchia   +6 more
openalex   +1 more source

The Effect of Bcr-Abl Protein Tyrosine Kinase on Maturation and Proliferation of Primitive Haematopoietic Cells [PDF]

open access: gold, 2000
Anne‐Marie Buckle   +6 more
openalex   +1 more source

Rational Approach to New Chemical Entities with Antiproliferative Activity on Ab1 Tyrosine Kinase Encoded by the BCR-ABL Gene: An Hierarchical Biochemoinformatics Analysis. [PDF]

open access: yesPharmaceuticals (Basel)
Sanches VHDS   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy